Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Perrigo Co (PRGO)  
$26.85 0.54 (1.97%) as of 4:30 Fri 6/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 136,480,000
Market Cap: 3.66(B)
Last Volume: 503,160 Avg Vol: 501,799
52 Week Range: $26.23 - $39.94
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Related Products

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P 400 MIDCAP
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 1400
  Page 23 of 56  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kochan Sharon Executive VP U.S. Generics   •       –      –    2011-02-14 4 S $73.90 $191,253 D/D (2,588) 4,425     -
   Kochan Sharon Executive VP U.S. Generics   •       –      –    2011-02-14 4 OE $35.85 $92,780 D/D 2,588 7,013     -
   Jandernoa Michael J Director   –       •      –    2011-02-11 4 GD $0.00 $0 I/I 705 1,060,588     -
   Morris Herman Jr Director   –       •      –    2011-02-11 4 S $73.47 $289,619 D/D (3,942) 15,924     -
   Morris Herman Jr Director   –       •      –    2011-02-11 4 OE $14.12 $55,661 D/D 3,942 19,866     -
   Needham Jeffrey Sr. VP Commercial Business Dev   •       –      –    2011-02-11 4 S $73.16 $504,324 D/D (6,893) 7,718     -
   Needham Jeffrey Sr. VP Commercial Business Dev   •       –      –    2011-02-11 4 OE $14.69 $57,188 D/D 3,893 14,611     -
   Farrington Thomas Senior VP and CIO   •       –      –    2011-02-11 4 S $71.76 $243,371 D/D (3,391) 1,903     -
   Farrington Thomas Senior VP and CIO   •       –      –    2011-02-11 4 OE $30.06 $111,533 D/D 3,391 3,636     -
   Gottfried Ran Director   –       •      –    2011-02-11 4 S $73.07 $424,844 D/D (5,814) 9,986     -
   Gottfried Ran Director   –       •      –    2011-02-11 4 OE $16.77 $97,501 D/D 5,814 15,800     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-11 4 S $71.90 $258,552 D/D (3,596) 3,326     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-11 4 OE $35.85 $128,917 D/D 3,596 6,922     -
   Jandernoa Michael J Director   –       •      –    2011-02-11 4 S $72.07 $871,706 I/I (12,000) 1,132,399     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-10 4 S $71.81 $1,076,292 D/D (14,973) 3,326     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-10 4 OE $14.69 $202,821 D/D 12,161 7,487     -
   Jandernoa Michael J Director   –       •      –    2011-02-10 4 S $71.84 $15,152,858 I/I (210,903) 1,144,399     -
   Jandernoa Michael J Director   –       •      –    2011-02-09 4 GD $0.00 $0 I/I 570 1,061,293     -
   Jandernoa Michael J Director   –       •      –    2011-02-09 4 S $71.70 $8,378,391 I/I (116,779) 1,355,302     -
   Jandernoa Michael J Director   –       •      –    2011-02-08 4 GD $0.00 $0 I/I 4,037 1,061,863     -
   Jandernoa Michael J Director   –       •      –    2011-02-08 4 S $71.64 $5,730,952 I/I (80,000) 46,441     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-08 4 S $71.91 $200,342 D/D (2,786) 6,138     -
   Kochan Sharon Executive VP U.S. Generics   •       –      –    2011-02-08 4 S $71.90 $224,112 D/D (3,117) 4,425     -
   Papa Joseph C President and CEOChairman   •       •      –    2011-02-07 4 GD $0.00 $0 D/D 700 121,337     -
   Lebel Refael EVP & GM Perrigo Israel   •       –      –    2011-02-07 4 S $71.53 $30,043 D/D (420) 8,924     -
  1400 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 23 of 56
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us